REARDON ANDREW (CLO & Secretary) sold 10.8% of their position (5K shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $1.01M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+5K
Price / share
$52.27
Trade value
$261.35K
% of position
Common Stock
Shares
−460.00
Price / share
$198.85
Trade value
$91.47K
% of position
Common Stock
Shares
−1.30K
Price / share
$199.72
Trade value
$260.04K
% of position
Common Stock
Shares
−1.24K
Price / share
$200.94
Trade value
$248.77K
% of position
Common Stock
Shares
−700.00
Price / share
$201.90
Trade value
$141.33K
% of position
Common Stock
Shares
−963.00
Price / share
$203.22
Trade value
$195.70K
% of position
Common Stock
Shares
−337.00
Price / share
$204.50
Trade value
$68.92K
% of position
Net shares
+0.00
Net value
-$744.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | M · Option Exercise | +5K | $52.27 | $261.35K | 12.1% | 41.38K | 46.38K |
| Common Stock Direct | 4/1/2026 | S · Sale | −460.00 | $198.85 | $91.47K | 1.0% | 46.38K | 45.92K |
| Common Stock Direct | 4/1/2026 | S · Sale | −1.30K | $199.72 | $260.04K | 2.8% | 45.92K | 44.62K |
| Common Stock Direct | 4/1/2026 | S · Sale | −1.24K | $200.94 | $248.77K | 2.8% | 44.62K | 43.38K |
| Common Stock Direct | 4/1/2026 | S · Sale | −700.00 | $201.90 | $141.33K | 1.6% | 43.38K | 42.68K |
| Common Stock Direct | 4/1/2026 | S · Sale | −963.00 | $203.22 | $195.70K | 2.3% | 42.68K | 41.72K |
| Common Stock Direct | 4/1/2026 | S · Sale | −337.00 | $204.50 | $68.92K | 0.8% | 41.72K | 41.38K |
| Total | +0.00 | -$744.87K | ||||||
Employee Stock Option (right to buy)
Common Stock
5K shares
Shares
−5K
Strike price
52.27
Held after
49.44K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock5K shares | 4/1/2026 | M · Option Exercise | −5K | 52.27 | — | 49.44K |